DENSE-AIR
Dense Air & Dublin City Council win the 2019 Small Cell Forum Award for Social Impact – ‘Promoting Small Cells for Social/Economic/Environmental Development’. It follows successful completion of the first phase of a ground breaking 5G research and development network in Dublin’s Docklands delivered as part of the Dublin City Council (DCC) ‘Smart Docklands’ initiative.
This strategic partnership between Dense Air and DCC announced in January 2018 was intended to provide a framework for the large-scale deployment of a “pervasive” 5G connectivity solution across Dublin, and also intended to develop a blue print for future deployments globally. The initial findings have demonstrated that Neutral Host Small Cells can provide unrivalled benefits to cities and mobile operators.
Working with City council departments, national agencies, building owners and the Science Foundation Ireland CONNECT Research Centre for future networks based in TCD, Dense Air have focused on understanding how best to deploy small cells on city owned street assets build neutral-host infrastructure that can be used simultaneously, by multiple mobile network providers and private networks to simplify the small cell installation process. Having an efficient, affordable, scalable and repeatable processes, are key factors in deploying 5G small cells networks, where densification and improved indoor performance will require access to city street assets including lamp posts and traffic lights.
The judging panel stated that: “There are many interesting smart city projects involving small cells but the collaboration between Dense Air and Dublin City Council stands out for the variety of services supported, and well-quantified benefits to citizens, businesses and visitors The judges were also impressed by the neutral host model, which they believe will be very significant in lowering barriers to deployment of large networks.”
Jamie Cudden, Smart City Program Manager said:“Dublin City Council is delighted to be recognised by the Small Cell Forum for our collaboration with Dense Air. The delivery of this project was only possible through collaboration with the CONNECT research centre for future networks, local building owners and the engagement of our wider Smart Docklands partner network.
“Pervasive connectivity offers cities a clear competitive advantage and we are now ideally placed to provide a perfect live 5G test environment for companies to work with us to trial services that can help us solve different challenges. Furthermore Dublin is now providing other cities globally a template for how they can realise the future 5G opportunity.”
Paul Senior , CEO of Dense Air said “We are absolutely thrilled to have received two awards at the 2019 Small Cell Forum World Summit in London. These awards recognise Dense Air’s unique neutral host business model based on densification using small cells, and deployment and engagement we have with cities, namely Dublin City Council.”
Building on the success of this project, Dublin City Council will host the prestigious Harvard TECH Innovators Forum in partnership with Dense Air from 7-9th October 2019; Bringing together city technology leaders from across the world to share emerging best practice for 5G deployments and showcasing the Dublin Docklands 5G Pervasive Network.
Dr. David Ricketts, Innovation Fellow in the Technology in Entrepreneurship Center at Harvard (TECH) comments that, ”We are delighted to bring together cities in Dublin to share best practice experiences on how they can manage disruptive technologies in a way that will allow us to build better communities for everyone. This unique gathering will bring the top global city technology leaders together to better understand how cities can best leverage and lead on the 5G opportunity.”
https://theinnovatorsforum.org/
Dense Air is headquartered in London, UK and has offices in the target launch markets of Ireland, Belgium, Portugal, Australia & New Zealand. Dense Air provides a unique “carrier of carriers” wholesale neutral host small cell services to deliver cost-effective densification to existing mobile carriers or service providers. Dense Air is conducting extensive trials and proof-of-concepts in 2019 and will offer commercial services in 2020. Dense Air provides small cell services in Ireland based on licensed 3.4-3.8GHz radio spectrum awarded by Ireland regulator in 2017.
Dublin City Council (DCC) is leading a series of innovative partnerships with world-leading technology companies through its Smart Dublin initiative. The Smart Docklands district was set up in February 2018 to deliver and fast-track smart city projects and deployments and understand the different types of connectivity and networks that would enable future cities. This was established in partnership with CONNECT, a national research centre for connectivity and future networks. Smart Docklands was a first of its kind in Ireland, where the municipality and academia have created a dedicated Project Management Office (PMO) to play an independent role amongst multiple stakeholders, from global technology companies to local residents’ groups, from academic institutions to international property developers, innovative start-ups and SMEs to fast track emerging smart city opportunities. http://smartdocklands.ie/
View source version on businesswire.com: https://www.businesswire.com/news/home/20190605005708/en/
Contact:
Dense Air Paul Coffey Tel: 01895 467100 www.denseair.net
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body5.12.2025 07:00:00 CET | Press release
Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1 Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs The certification validates Sculptra’s safety performance, efficacy, and quality, reinforcing Galderma’s commitment to innovation and meeting evolving patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its
Northern Escape Heli-Skiing Takes the Title of “World’s Best Heli-Ski-Operator” for the 4th Year Running5.12.2025 02:40:00 CET | Press release
4x World’s Best Heli-Skiing Operation near Terrace, BC Northern Escape Heli-Skiing (NEH) has been named World’s Best Heli-Ski Operator 2025 by the World Ski Awards, marking its fourth straight victory following years 2022, 2023 and 2024. This recognition places NEH amongst an elite group of ski tourism operators consistently voted best in the world by industry leaders and enthusiasts alike. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204074550/en/ A four-year run built on reliability NEH operates in British Columbia’s Skeena Mountains, where deep northern snow and vast terrain come together with small-group heli-skiing and heli snowboarding. When helicopters can’t safely fly, NEH has cat skiing readily available as a backup — an exceedingly rare offering in this industry. The operation spans over 833,571 wild acres of alpine bowls, glaciers and old-growth tree skiing. The NEH experience Guests choose from three lodge f
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance5.12.2025 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollment in Q1 2026, initially evaluating patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck, and ovarian/gynecological cancers. IDE034 is a bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and licensed to IDEAYA in July 2024. The IND clearance marks an important milestone for this licensed program, supporting subsequent clinical development of IDE034, while highlighting Biocytogen’s technical capabilities in bispecific ADC discovery and development. Dr. Yue
Helical Fusion, Developer of Next-Generation Clean Energy Through Nuclear Fusion, Completes USD 5.5M Series A Extension Round5.12.2025 01:00:00 CET | Press release
Stakeholder base expands with participation from an individual-investor-oriented fund, alongside corporate and individual investors, bringing Total Funding to USD 38M Helical Fusion Co., Ltd. (Head Office: Chuo-ku, Tokyo; CEO: Takaya Taguchi; hereafter “Helical Fusion”), which is developing a next-generation energy source using Japan’s original Helical Stellarator technology to realize commercially viable fusion power plant in the 2030s, announced the completion of its Series A Extension round, raising approximately USD 5.5 million (≈ JPY 870 million). The round included investments from “Ecrowd NEXT”, a fund designed for individual investors, as well as multiple corporate investors and individual investors. As a result, Helical Fusion’s total Series A funding, including loans, amounts to approximately USD 21 million (≈ JPY 3.2 billion), bringing the company’s cumulative fundraising—including grants and loans—to approximately USD 38 million (≈ JPY 6.0 billion). With this funding, Helic
Andersen Consulting udvider sin tilstedeværelse gennem samarbejde med Hilal Technology4.12.2025 23:04:00 CET | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Hilal Technology for at styrke sine kompetencer inden for digital infrastruktur, cybersikkerhed og AI. Med tilstedeværelse i Bahrain, Saudi-Arabien, De Forenede Arabiske Emirater, Oman og Indien leverer Hilal Technology et komplet spektrum af digital infrastruktur og managed services inden for cloudcomputing, cybersikkerhed, enterprise ai og systemintegration. Deres ydelser omfatter cloudtjenester, sikkerheds- og netværksdrift, implementering af ERP og applikationer samt udvikling af generative ai-kapaciteter. Med et team på mere end 250 fagfolk servicerer firmaet en bred vifte af brancher, herunder den finansielle sektor, olie og gas, logistik og den offentlige sektor. "Transformation er mere end systemer; det handler om parathed, tillid og løbende samarbejde," udtaler Roshan George, direktør for Hilal Technology. "Vi er begejstrede for at samarbejde med Andersen Consulting og levere skalerbare løsninger, der matcher tempoet i den dig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom